SA variant unlikely to fully negate Covid-19 vaccines, scientist says

play article
Subscribers can listen to this article
A nurse receives the Moderna Covid-19 vaccine at Northwell Health's Long Island Jewish Valley Stream Hospital on 21 December 2020 in Valley Stream, New York.
A nurse receives the Moderna Covid-19 vaccine at Northwell Health's Long Island Jewish Valley Stream Hospital on 21 December 2020 in Valley Stream, New York.
Eduardo Munoz-Pool/Getty Images


A variant of the Covid-19 coronavirus first detected in South Africa is unlikely to completely negate the immunising effects of vaccines, a researcher studying it told Reuters.

British scientists expressed concern on Monday that Covid-19 vaccines may not be able to protect against the variant identified by South African genomics scientists and which has spread internationally.

Richard Lessells, an infectious disease expert at the KwaZulu-Natal Research Innovation and Sequencing Platform, which played a central role in identifying the variant known as 501Y.V2, said his understanding was that the comments were not based on any new data but on shared information.

“They are voicing the same concerns that we articulated when we first released this information, that the pattern of mutations did give us concern,” Lessells said on Tuesday.

Read: SA medical aids to fund Covid-19 vaccines for broader population

South African researchers are studying the effects of mutations in the variant, including whether natural immunity from exposure to older variants provides protection against reinfection by the new variant.

Preliminary results from those studies may be ready by the end of this week, Lessells said.

Scientists have identified more than 20 mutations in the 501Y.V2 variant, including several in the spike protein the virus uses to infect human cells.

One of these is at a site that is believed to be important for neutralising antibodies and is not found in another coronavirus variant discovered in Britain, Lessells said.

“Why we've been a bit cautious about flagging out the concern about the (effectiveness of) vaccines is that for many of the vaccines they are thought to induce quite a broad immune response,” he said.

That broad response could target different parts of the spike protein, not just one, he added.

Read: SA’s Covid-19 vaccine fiasco: Ramaphosa needs to wield the axe

“That’s why we think that although these mutations may have some effect, they are very unlikely to completely negate the effect of the vaccines,” Lessells said.

The health department acknowledged questions from Reuters but did not give an immediate response. The country has recorded more than 1.1 million Covid-19 cases and more than 30 000 deaths, the most on the continent.

Public Health England has said there is no evidence to suggest Covid-19 vaccines would not protect against mutated coronavirus variants.

BioNTech chief executive Ugur Sahin said in an interview last week that his company’s vaccine, which uses messenger RNA to instruct the human immune system to fight the virus, should be able to protect against the British variant.

Meanwhile, the World Health Organization’s technical chief on Covid-19, Maria Van Kerkhove, said on Tuesday that there is no indication that the coronavirus variant identified in South Africa is more transmissible than the one spreading fast in Britain.

– Reuters

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24


Read the digital editions of City Press here.
Read now
Voting Booth
According to a letter Health Minister Joe Phaahla sent to MECs, the country is ready to get rid of masks in public as a health protocol. Is it time to go maskless?
Please select an option Oops! Something went wrong, please try again later.
About time
64% - 137 votes
36% - 76 votes